Investor Relations
INVESTORS & MEDIA
Archived Presentations
Jan 11
2021
Regeneron J.P. Morgan 2021 Presentation
Dec 07
2020
Regeneron Oncology Investor Presentation, ASH 2020
Nov 06
2020
Regeneron Corporate Presentation November 2020
Oct 31
2020
Yancopoulos FOCIS Presentation
Sep 29
2020
Regeneron COVID-19 Program Update
Sep 08
2020
ERS 2020 Dupixent TRAVERSE LIBERTY ASTHMA LTS
Aug 12
2020
Corporate Presentation August 2020
Jun 12
2020
2020 Regeneron Shareholder Meeting Presentation
Jun 12
2020
Phase 2 of Pozelimab in PNH
Phase 2 of Pozelimab in PNH 756.2 KB
Jun 09
2020
Corporate Presentation June 2020
Jun 01
2020
Trial in Progress - Phase 1-2 for REGN5678 (PSMAxCD28) in mCRPC
Jun 01
2020
Phase 2 of Libtayo in Advanced CSCC - Three-year follow-up
Jun 01
2020
Trial in Progress - Phase 3 for Libtayo in Adjuvant CSCC
Jun 01
2020
Regeneron Oncology Investor Event, ASCO 2020 Presentation
Jun 01
2020
Trial in Progress - Phase 1-2 for REGN5093 (METxMET) in MET-Altered Advanced NSCLC
Jun 01
2020
Phase 2 of Libtayo in Advanced CSCC - Post Hoc Exploratory Analysis
Apr 06
2020
Updates to Regeneron Accounting
Mar 30
2020
ACC.20
Mar 02
2020
Cowen 40th Annual Healthcare Conference Presentation
Feb 09
2020
Angiogenesis, Exudation, and Degeneration 2020
Jan 13
2020
Annual J.P. Morgan Healthcare Conference
JP Morgan 2019 1.7 MB
Financial Overview 2019 505.7 KB
Financial Overview 2018 1.3 MB
Financial Overview 2017 454.2 KB
Financial Overview 2016 791.6 KB
Financial Overview 2015 669.5 KB
Dec 08
2019
American Society of Hematology (ASH) 2019 Annual Meeting
Nov 07
2019
Regeneron Oncology Strategy
Sep 30
2019
European Society For Medical Oncology (ESMO) Congress 2019
Jun 15
2019
European Hematology Association (EHA) 2019 Annual Meeting
REGN1979 in patients with R/R B-NHL 787.6 KB
Jun 01
2019
American Society of Clinical Oncology (ASCO) 2019 Annual Meeting
Apr 10
2019
PEGS Boston Summit Presentation
Mar 01
2019
ASCO-SITC 2019
Feb 25
2019
2019 AAAAI Annual Meeting
Phase 3 SINUS-52 Study poster 679.8 KB
Feb 09
2019
Angiogenesis, Exudation, and Degeneration 2019
Phase 3 PANORAMA 52 Week Data 20.6 MB
Dec 01
2018
ASH 2018
View Presentation 789.4 KB
View Presentation 231.7 KB
Jul 24
2018
ASRS 2018
Phase 2 RUBY Trial - Heier 3.4 MB